•  Nitric Oxide
  •  Products
  •  Innovation
  •  Investors
  •  Connect

Nu-Med Plus
  •  Nitric Oxide
  •  Products
  •  Innovation
  •  Investors
  •  Connect

Nu-Med Plus, Inc. Advances Blood and Plasma Transfusion Technology with New Patent

Posted on November 14, 2018
Posted in Investor News

Post navigation

Letter From Our President
Nu-Med Plus’ Blood Transfusion Technology Featured in Deseret News

Connect

Jeff Robins | CEO
jeff@nu-medplus.com
801.746.3570
LinkedIn
Twitter

Offices

Corporate 455 E. 500 S.
Suite #203
Salt Lake City UT, 84111

Lab 1266 S 1380 W
Orem UT, 84111

News

Stay Up to Date On Nu-Med Plus News

Legal

SEC Documents Shareholder Letters Privacy Policy

Crunchbase

Profile

© 2022 Nu-Med Plus All Rights Reserved

Site designed + built by Wildern